Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEPAFENAC Cause Wrong technique in product usage process? 32 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Wrong technique in product usage process have been filed in association with NEPAFENAC (ILEVRO). This represents 1.8% of all adverse event reports for NEPAFENAC.

32
Reports of Wrong technique in product usage process with NEPAFENAC
1.8%
of all NEPAFENAC reports
0
Deaths
8
Hospitalizations

How Dangerous Is Wrong technique in product usage process From NEPAFENAC?

Of the 32 reports, 8 (25.0%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEPAFENAC. However, 32 reports have been filed with the FAERS database.

What Other Side Effects Does NEPAFENAC Cause?

Eye pain (393) Drug ineffective (270) Treatment failure (208) Vision blurred (133) Eye irritation (67) Visual impairment (66) Product quality issue (57) Liquid product physical issue (55) Off label use (43) Cystoid macular oedema (42)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which NEPAFENAC Alternatives Have Lower Wrong technique in product usage process Risk?

NEPAFENAC vs NERATINIB NEPAFENAC vs NETARSUDIL NEPAFENAC vs NETUPITANT\PALONOSETRON NEPAFENAC vs NEULASTA NEPAFENAC vs NEUPOGEN

Related Pages

NEPAFENAC Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process NEPAFENAC Demographics